Skip to main content

Funding Opportunities

Vanderbilt-Ingram Cancer Center regularly solicits applications for pilot funding to support basic, translational, clinical or collaborative cancer research. Pilot funds allow investigators to collect preliminary data to support an application for independent research support through extramural, peer-reviewed funding. Over the past five years, the Cancer Center awarded $4.1 million to fund 98 pilot projects. This investment led to the acquisition of more than $41 million in extramurally funded grants – a 985 percent return on investment.

Calls for proposals are distributed throughout the year by email, online, and in campus publications. Award amounts and submission deadlines vary. All pilot project awards are funded for one-year periods.

For more information, contact us at vicc.fundingopportunity@vumc.org

VICC Multi-Tier Developmental Research Funding

Complete an online application to apply for this funding

Submit Your Proposal

 

Complete this online application to apply for pilot funding

Funding Sources

Source Eligibility Funding Cycle Amount Principal Investigator
Multi-Tier Developmental Research Funding Vanderbilt-Ingram Cancer Center members only Variable Three Tiers Jennifer Pietenpol, Ph.D.
American Cancer Society-Institutional Research Grants (ACS-IRG) Open to junior faculty in any school/department at Vanderbilt University Spring & Fall up to $30,000 David Cortez, Ph.D
Cancer Center Support Grant (CCSG) Vanderbilt-Ingram Cancer Center members only Variable up to $35,000  Jennifer Pietenpol, Ph.D.
Breast SPORE DRP Tenured and tenure-track faculty at Vanderbilt, Meharry Medical College or Tennessee State University with membership in the Vanderbilt-Ingram Cancer Center Variable up to $50,000 Jennifer Pietenpol, Ph.D.
Ben Ho Park, M.D., Ph.D.
Breast SPORE CEP The Breast SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University.  Variable up to $50,000 Jennifer Pietenpol, Ph.D.
Ben Ho Park, M.D., Ph.D.
GI SPORE DRP Tenured and tenure-track faculty at Vanderbilt, Meharry Medical College or Tennessee State University Variable up to $50,000 Robert Coffey, M.D.
GI SPORE CEP The GI SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University.  Variable up to $50,000 Robert Coffey, M.D.
VICC Ambassadors Junior faculty at Vanderbilt Fall $50,000 Scott Hiebert, Ph.D. 

 

American Cancer Society-Institutional Research Grants

The American Cancer Society (ACS)-Institutional Research Grant (IRG) is the major source of support at Vanderbilt University for young investigators building cancer research programs. These funds provide seed money to support junior faculty members with an interest in cancer research who do not have national grant support of their own or who have not received prior support from the IRG. The ACS defines junior faculty as investigators at the rank of assistant professor or equivalent who are eligible to apply as a principal investigator for grant support from national agencies. Eligible investigators must be within six years of their first independent faculty appointment. Awards are made for a one-year project period and the maximum allocation is limited to $30,000. If sufficient progress has been made toward the project goals, IRG support may be renewed for an additional year. Funds are available to all schools at Vanderbilt University.

Back to 'Funding Sources'

 

Cancer Center Support Grant Pilot Projects

Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly innovative pilot projects focusing on proof-of-concept or translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant awards or clinical trial; (3) projects that closely align with the Cancer Center's strategic plan and enhance key initiatives; and (4) pilot funding for junior investigators to jump-start independent projects or for more senior investigators looking to study a novel idea derived from discovery.

Back to 'Funding Sources'

 

SPORE Pilot Projects

The Breast SPORE Developmental Research Program provides pilot funding to promote excellent translational research in breast cancer. These funds allow early, high-risk research to move solid basic science findings toward clinical application, as well as the migration of provocative clinical observations back to the laboratory in order to understand their mechanistic basis. Main criteria for selection and funding of developmental (pilot) projects include scientific merit, relevance to mammary biology and/or breast cancer, collaboration and potential for extramural peer-reviewed funding. There also is an emphasis on utilization of emerging technologies and on young investigators.

Current Opportunity: Breast SPORE Developmental Research Program Funding

The Breast SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into breast cancer research, high risk/high gain projects, and emerging technologies and their application to breast cancer research. Award amounts of up to $50,000 per project per year are available.

Current Opportunity: Breast SPORE Career Enhancement Program Funding

 

The GI SPORE Developmental Research Program solicits applications once a year in the spring from investigators at Vanderbilt, Meharry Medical College or Tennessee State University. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into GI cancer research, high risk/high gain projects, and emerging technologies and their application to GI cancer research. Award amounts of up to $50,000 per project per year are available.

Current Opportunity:  GI SPORE Developmental Research Program Pilot Project Funding

The GI SPORE Career Enhancement Program solicits applications yearly from investigators at Vanderbilt, Meharry Medical College or Tennessee State University. Proposals are reviewed for scientific merit and the likelihood of leading to extramural funding. Special emphasis is placed on attracting young investigators into GI cancer research, high risk/high gain projects, and emerging technologies and their application to GI cancer research. Award amounts of up to $50,000 per project per year are available.

Current Opportunity:  GI SPORE Career Enhancement Program Funding

Back to 'Funding Sources'

 

VICC Ambassadors

The VICC Ambassadors are the next generation of philanthropists committed to winning the battle against cancer by awarding Discovery Grants to promising young researchers at the Vanderbilt-Ingram Cancer Center. Discovery Grants allow skilled researchers to pursue exciting discoveries in basic and clinical science—aiding our understanding of disease processes and leading to better methods of prevention, diagnosis and treatment. For Vanderbilt physicians and scientists this funding not only yields early results, it helps develop the ideas that grow to large federally funded projects aimed at transformative breakthroughs in care. Three grants of $50,000 each are awarded every fall.

Back to 'Funding Sources'

 

Other Funding Resources

Melanoma Research Alliance
The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. 
Additional Details
October 5, 2022

The Pietenpol P3 Catalyst Awards
The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to support impactful cancer-related projects at any stage of research (i.e., pilot projects, need for translation, etc.) from any stage faculty member. The goal of this award is to provide funding to support paradigm-shifting, practice-changing, or policy-creating research, named for the former VICC Director, Jennifer Pietenpol, PhD, who challenged investigators with these inspirational goals to drive exceptional research, clinical care, and support for our patients. Both single PI and collaborative project proposals are eligible for an annual award of $50,000 (direct costs). The application and evaluation process will be in two stages. First, applicants will submit a one-page letter of intent (LOI) that contains the Title, Background, Hypothesis, Specific Aims (including the Approach), and a brief paragraph regarding cancer relevance to the “P3”. Top candidates from the LOIs submitted will be invited to a “Shark Tank” style in person/hybrid meeting to provide a five-minute presentation of their work followed by a five-minute question and answer session. Projects will be evaluated and voted upon at the end of this meeting, with awardees notified shortly thereafter. Lay audience members who helped raise philanthropic funds to support this funding will also be invited to participate and vote. To submit your application electronically, please submit a single PDF containing all documentation through the VICC Pilot Project Application Portal. A link to the VICC Pilot Project Application Portal can also be found at the top right-hand corner of the VICC Funding Opportunities web page (http://www.vicc.org/research/funding/). In the VICC Pilot Project Application Portal, please select “Other” from the dropdown options, and specify the program title as “Pietenpol P3.” Finalists will be notified in November 2022, with presentations scheduled thereafter. If you have further questions or comments, please contact Jenn Beiner (jenn.beiner@vumc.org)
Additional Details
October 17, 2022

Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research 
Funding opportunities in honor of John Robert Lewis and Ruth Bader Ginsburg
Additional Details
October 18, 2022

NIH/NCI Cancer Target Discovery and Development Network
The Cancer Target Discovery and Development (CTD2) Network, a functional genomics initiative, bridges the gap between cancer genomics and biology. The Network aims to understand how tumor heterogeneity leads to drug resistance in order to develop optimal combinations of chemotherapy or small molecules in combination with immunotherapy. 
Additional Details
Rolling basis through October 6, 2022

NIH/NCI Research Specialist (Clinician Scientist) Award
The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for cancer research career continuity.
Additional Details
Rolling basis through October 6, 2023

*The VUMC Corporate & Foundation Relations team is happy to assist with proposal development for the above opportunities. Contact cfr@vumc.org for more information.